AAAAAA

   
Results: 1-14 |
Results: 14
Mortality risks, costs, and decision making in transfusion medicine - Reply
Authors: Blumberg, N Heal, JM
Citation: N. Blumberg et Jm. Heal, Mortality risks, costs, and decision making in transfusion medicine - Reply, AM J CLIN P, 115(6), 2001, pp. 935-936
Platelet washing to prevent recurrent febrile reactions to leucocyte-reduced transfusions
Authors: Vo, TD Cowles, J Heal, JM Blumberg, N
Citation: Td. Vo et al., Platelet washing to prevent recurrent febrile reactions to leucocyte-reduced transfusions, TRANSFUS M, 11(1), 2001, pp. 45-47
Percutaneous release of trigger digits
Authors: Blumberg, N Arbel, R Dekel, S
Citation: N. Blumberg et al., Percutaneous release of trigger digits, J HAND S-BR, 26(3), 2001, pp. 256-257
Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion
Authors: Phipps, RP Kaufman, J Blumberg, N
Citation: Rp. Phipps et al., Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion, LANCET, 357(9273), 2001, pp. 2023-2024
WBC-reduced blood transfusions and clinical outcome in children with acutelymphoid leukemia
Authors: Rios, JA Korones, DN Heal, JM Blumberg, N
Citation: Ja. Rios et al., WBC-reduced blood transfusions and clinical outcome in children with acutelymphoid leukemia, TRANSFUSION, 41(7), 2001, pp. 873-877
Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery
Authors: Blumberg, N Heal, JM Hicks, GL Risher, WH
Citation: N. Blumberg et al., Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery, TRANSFUSION, 41(6), 2001, pp. 790-793
Posttransfusion purpura secondary to an alloantibody reactive with HPA-5a (Br-b)
Authors: Anolik, JH Blumberg, N Snider, J Francis, CW
Citation: Jh. Anolik et al., Posttransfusion purpura secondary to an alloantibody reactive with HPA-5a (Br-b), TRANSFUSION, 41(5), 2001, pp. 633-636
Question - I'm trying to find out what others are paying for a unit of leukocyte-reduced RBCs.
Authors: Blumberg, N
Citation: N. Blumberg, Question - I'm trying to find out what others are paying for a unit of leukocyte-reduced RBCs., LAB MED, 32(7), 2001, pp. 351-351
Mortality risks, costs, and decision making in transfusion medicine
Authors: Blumberg, N Heal, JM
Citation: N. Blumberg et Jm. Heal, Mortality risks, costs, and decision making in transfusion medicine, AM J CLIN P, 114(6), 2000, pp. 934-937
Essential papers on posttraumatic stress disorder
Authors: Blumberg, N
Citation: N. Blumberg, Essential papers on posttraumatic stress disorder, J AM A PSYC, 28(3), 2000, pp. 376-376
Universal WBC reduction and patient advocacy
Authors: Goldfinger, D Klapper, E Pepkowitz, SH Millar, SI Heal, JM Blumberg, N Wuest, D Reich, L Mayer, K
Citation: D. Goldfinger et al., Universal WBC reduction and patient advocacy, TRANSFUSION, 40(12), 2000, pp. 1545-1546
The second century of ABO: and now for something completely different
Authors: Heal, JM Blumberg, N
Citation: Jm. Heal et N. Blumberg, The second century of ABO: and now for something completely different, TRANSFUSION, 39(11-12), 1999, pp. 1155-1159
The costs and consequences of management pads and politically driven regulatory oversight - The case of blood transfusion
Authors: Blumberg, N
Citation: N. Blumberg, The costs and consequences of management pads and politically driven regulatory oversight - The case of blood transfusion, ARCH PATH L, 123(7), 1999, pp. 580-584
Recombinant erythropoietin and blood transfusions in cancer chemotherapy-induced anemia
Authors: Griggs, JJ Blumberg, N
Citation: Jj. Griggs et N. Blumberg, Recombinant erythropoietin and blood transfusions in cancer chemotherapy-induced anemia, ANTI-CANC D, 9(10), 1998, pp. 925-932
Risultati: 1-14 |